Portfolio company
Alpine Immune Sciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biopharmaceutical company develops protein-based immunotherapies to treat autoimmune and inflammatory diseases for patients with conditions like kidney disease.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Alpine Immune
This company develops protein-based immunotherapies for patients with autoimmune and inflammatory diseases, such as IgA nephropathy and systemic lupus erythematosus.
Jasper Therapeutics
This company develops antibody therapies for patients with immune-mediated diseases, including renal disorders, mast cell conditions and paroxysmal nocturnal haemoglobinuria.
Chinook Therapeutics
This biopharmaceutical company develops precision medicines for patients with rare and severe chronic kidney diseases.
Odyssey Therapeutics
This biopharmaceutical company develops oral small molecule and protein medicines for patients with autoimmune and inflammatory diseases.
AUPH
The company develops and provides pharmaceutical therapies for adult patients living with autoimmune diseases such as active lupus nephritis.
Clim Bio
This biotechnology company develops antibody-based medicines for patients with immune-mediated diseases such as lupus and IgA nephropathy.
Purespring Therapeutics
This company develops gene therapies for patients with chronic renal diseases to preserve kidney function and treat conditions like IgA nephropathy.
Veratx
The company develops medicines for patients with autoimmune diseases, focusing on the treatment of kidney conditions such as IgA nephropathy.
